iRhythm Technologies Inc (IRTC)
$89.93 $3.43 (3.95%) 4:38 PM 12/11/24
NASDAQ | $USD | Medical DevicesStock Data
-
Market Cap
$2.67B -
Day's Range
$87.45 - $92.38 -
Volume
358,030 -
52 Week Low / High
$55.92 - $124.12 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 8
- Strong Buy
- 3
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $126.67
- Target Price
Company News
-
iRhythm Technologies (IRTC) Slipped on Regulatory Issues — Oct 16th, 2024
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return...
-
Irhythm Technologies Outlines Growth and Market Leadership Strategy — Oct 11th, 2024
Irhythm Technologies ( (IRTC) ) has issued an announcement. iRhythm Technologies, Inc. has actively engaged its shareholders with an investor presentation outlining its achievements and strategic focus areas, including market expansion opportunities, innovation, and operational efficiency...
-
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024 — Oct 16th, 2024
iRhythm SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third qu...
-
Irhythm Technologies Outlines Growth and Market Leadership Strategy — Oct 11th, 2024
Irhythm Technologies ( (IRTC) ) has issued an announcement. iRhythm Technologies, Inc. has actively engaged its shareholders with an investor presentation outlining its achievements and strategic focus areas, including market expansion opportunities, innovation, and operational efficiency...
-
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024 — Oct 16th, 2024
iRhythm SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third qu...
-
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024 — Oct 16th, 2024
iRhythm SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third qu...
-
Irhythm Technologies Outlines Growth and Market Leadership Strategy — Oct 11th, 2024
Irhythm Technologies ( (IRTC) ) has issued an announcement. iRhythm Technologies, Inc. has actively engaged its shareholders with an investor presentation outlining its achievements and strategic focus areas, including market expansion opportunities, innovation, and operational efficiency...
-
iRhythm's Zio ECG System Gets Approval in Japan, Stock Falls — Sep 13th, 2024
iRhythm Technologies, Inc. IRTC has received regulatory approval from Japan’s Pharmaceutical and Medical Device Agency for its Zio long-term continuous ECG monitoring (LTCM) system. The Zio system, which provides 14 days of continuous heart monitoring, combines a wearable patch device w...
-
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024 — Oct 16th, 2024
iRhythm SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third qu...
-
iRhythm Technologies (IRTC) Slipped on Regulatory Issues — Oct 16th, 2024
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return...
-
Irhythm Technologies Outlines Growth and Market Leadership Strategy — Oct 11th, 2024
Irhythm Technologies ( (IRTC) ) has issued an announcement. iRhythm Technologies, Inc. has actively engaged its shareholders with an investor presentation outlining its achievements and strategic focus areas, including market expansion opportunities, innovation, and operational efficiency...
-
Irhythm Technologies Outlines Growth and Market Leadership Strategy — Oct 11th, 2024
Irhythm Technologies ( (IRTC) ) has issued an announcement. iRhythm Technologies, Inc. has actively engaged its shareholders with an investor presentation outlining its achievements and strategic focus areas, including market expansion opportunities, innovation, and operational efficiency...
-
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024 — Oct 16th, 2024
iRhythm SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third qu...
-
iRhythm Technologies (IRTC) Slipped on Regulatory Issues — Oct 16th, 2024
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return...
-
iRhythm Technologies (IRTC) Slipped on Regulatory Issues — Oct 16th, 2024
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return...
-
Irhythm Technologies Outlines Growth and Market Leadership Strategy — Oct 11th, 2024
Irhythm Technologies ( (IRTC) ) has issued an announcement. iRhythm Technologies, Inc. has actively engaged its shareholders with an investor presentation outlining its achievements and strategic focus areas, including market expansion opportunities, innovation, and operational efficiency...
-
Irhythm Technologies Outlines Growth and Market Leadership Strategy — Oct 11th, 2024
Irhythm Technologies ( (IRTC) ) has issued an announcement. iRhythm Technologies, Inc. has actively engaged its shareholders with an investor presentation outlining its achievements and strategic focus areas, including market expansion opportunities, innovation, and operational efficiency...
-
iRhythm Technologies (IRTC) Slipped on Regulatory Issues — Oct 16th, 2024
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return...
-
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024 — Oct 16th, 2024
iRhythm SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third qu...
-
iRhythm Technologies (IRTC) Slipped on Regulatory Issues — Oct 16th, 2024
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return...
-
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024 — Oct 16th, 2024
iRhythm SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third qu...
-
iRhythm Technologies (IRTC) Slipped on Regulatory Issues — Oct 16th, 2024
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return...
-
Irhythm Technologies Outlines Growth and Market Leadership Strategy — Oct 11th, 2024
Irhythm Technologies ( (IRTC) ) has issued an announcement. iRhythm Technologies, Inc. has actively engaged its shareholders with an investor presentation outlining its achievements and strategic focus areas, including market expansion opportunities, innovation, and operational efficiency...
-
iRhythm Technologies (IRTC) Slipped on Regulatory Issues — Oct 16th, 2024
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return...
-
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024 — Oct 16th, 2024
iRhythm SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third qu...
Portfolio
Comprised of 1 portfolios